Waters Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a WAT research report →
Companywww.waters.com
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
- CEO
- Udit Batra
- IPO
- 1995
- Employees
- 7,600
- HQ
- Milford, MA, US
Price Chart
Valuation
- Market Cap
- $22.27B
- P/E
- 62.41
- P/S
- 5.90
- P/B
- 1.83
- EV/EBITDA
- 29.59
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 55.02%
- Op Margin
- 17.08%
- Net Margin
- 11.91%
- ROE
- 8.04%
- ROIC
- 2.44%
Growth & Income
- Revenue
- $3.17B · 6.99%
- Net Income
- $642.63M · 0.75%
- EPS
- $10.80 · 0.47%
- Op Income
- $893.22M
- FCF YoY
- -12.88%
Performance & Tape
- 52W High
- $414.15
- 52W Low
- $275.05
- 50D MA
- $314.66
- 200D MA
- $337.52
- Beta
- 1.14
- Avg Volume
- 1.28M
Get TickerSpark's AI analysis on WAT
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 12, 26 | Chaubal Amol | other | 239 |
| Apr 6, 26 | Bennett Jianqing | other | 302 |
| Mar 31, 26 | Jiang Wei | other | 64.06 |
| Mar 31, 26 | Knight Heather | other | 68.44 |
| Mar 16, 26 | Jiang Wei | buy | 500 |
| Mar 6, 26 | FEARON RICHARD H | buy | 1,000 |
| Mar 2, 26 | Batra Udit | other | 3,417 |
| Mar 2, 26 | Chaubal Amol | other | 709 |
| Mar 2, 26 | Bennett Jianqing | other | 410 |
| Feb 25, 26 | Carpio Robert L III | other | 4,884 |
Our WAT Coverage
View all →
Waters Corporation (WAT): Quality Growth Meets Integration Risk
Waters posted solid 2025 growth and enters 2026 with momentum, but the BD Biosciences & Diagnostic Solutions deal adds integration risk and a richer valuation. The stock looks like a Hold leaning to Buy on weakness as synergies and recurring revenue expansion offset execution concerns.
Waters Corporation (WAT) climbs 10% on Q1 beat
Waters Corporation (WAT) climbs after-hours after a strong first-quarter report beat revenue guidance and lifted full-year profit outlook. The move reflects investor confidence in the company’s newly expanded business after its $18.8 billion BD biosciences and diagnostics deal.
Want a deeper read on WAT?
Generate a full analyst-grade report — bull / bear case, price targets, valuation depth, and a complete financial breakdown.